Vivek Khanna

Analyst-Equity at

PFM Health Sciences LP

Consumer Services

Finance

Profile

Mr. Vivek Khanna is an Investment Partner at PFM Health Sciences LP.
Prior to joining PFM in 2012, Mr. Khanna was an Analyst at Catapult Partners/Millennium LLP (2011-2012).
Before Millennium, he was an Analyst /Sector Head at Argus/Sivik Healthcare (2002-2011).
Prior to Sivik Healthcare, he was an Executive Director of Equity Research with UBS Investment Bank (1999-2002), Vice President of Equity Research with Smith Barney (1993-1996) and an Analyst at Blue Cross Blue Shield of National Capital Area (1991-1993).
He is a graduate of Delhi University with a B.A. in Economics and received his MBA from the College of William and Mary.

Vivek Khanna active positions

Companies	Position	Start
PFM Health Sciences LP PFM Health Sciences LP Investment ManagersFinance PFM generally uses bottom-up analysis in an attempt to identify transformational changes, trends, investment themes and core investment opportunities across asset classes and geographies. Their investment strategies are currently (1) Healthcare, which primarily invests in the global healthcare industry, (2) Growth Equity, which primarily invests in growth equity healthcare investments and (3) Biotech Opportunities, which primarily invests in biotech investments. The firm utilizes certain co-investment vehicles from time to time for investment opportunities in privately held companies.	Analyst-Equity	01/01/2012

All active positions of Vivek Khanna

Training of Vivek Khanna

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Vivek Khanna's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
PFM Health Sciences LP PFM Health Sciences LP Investment ManagersFinance PFM generally uses bottom-up analysis in an attempt to identify transformational changes, trends, investment themes and core investment opportunities across asset classes and geographies. Their investment strategies are currently (1) Healthcare, which primarily invests in the global healthcare industry, (2) Growth Equity, which primarily invests in growth equity healthcare investments and (3) Biotech Opportunities, which primarily invests in biotech investments. The firm utilizes certain co-investment vehicles from time to time for investment opportunities in privately held companies.	Finance
The College of William & Mary The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Delhi University of Delhi Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services